Skip to main content
Top
Published in: Annals of Hematology 10/2010

01-10-2010 | Original Article

Expression of microRNA-451 in normal and thalassemic erythropoiesis

Authors: Saovaros Svasti, Shizuka Masaki, Tipparat Penglong, Yasunobu Abe, Pranee Winichagoon, Suthat Fucharoen, Tsukuru Umemura

Published in: Annals of Hematology | Issue 10/2010

Login to get access

Abstract

MicroRNAs (miRNAs) are negative regulators of gene expression that play an important role in hematopoiesis. Thalassemia, a defective globin synthesis leading to precipitate of excess unbound globins in red blood cell precursors, results in defective erythroid precursors and ineffective erythropoiesis. Expression pattern of miR-451, an erythroid-specific miRNA, was analyzed during differentiation of erythroid progenitors derived from normal and thalassemic peripheral blood CD34-positive cells, after 14 days of culture. A biphasic expression with transient up-regulation of miRNA-451 on day 3 of cultures was observed during thalassemic erythroid differentiation. In contrast, the expression pattern of the miR-451 in erythroid cells obtained from the other extravascular hemolytic anemia, i.e., hereditary spherocytosis patients showed no transient up-regulation of miR-451 on day 3 of cultures. Our results suggest that early erythroid progenitors in β-thalassemia have a dysregulated miRNA-451 expression program, and analysis of microRNA is a relevant approach to determine abnormalities of erythropoiesis.
Literature
1.
go back to reference Weatherall DJ, Clegg JB (2001) The thalassemia syndromes. Blackwell Science, MaldenCrossRef Weatherall DJ, Clegg JB (2001) The thalassemia syndromes. Blackwell Science, MaldenCrossRef
2.
go back to reference Yuan J, Angelucci E, Lucarelli G et al (1993) Accelerated programmed cell death (apoptosis) in erythroid precursors of patients with severe β-thalassemia (Cooley's anemia). Blood 82:374–377PubMed Yuan J, Angelucci E, Lucarelli G et al (1993) Accelerated programmed cell death (apoptosis) in erythroid precursors of patients with severe β-thalassemia (Cooley's anemia). Blood 82:374–377PubMed
3.
go back to reference Mathias LA, Fisher TC, Zeng L, Meiselman HJ, Weinberg KI, Hiti AL, Malik P (2000) Ineffective erythropoiesis in β-thalassemia major is due to apoptosis at the polychromatophilic normoblast stage. Exp Hematol 28:1343–1353CrossRefPubMed Mathias LA, Fisher TC, Zeng L, Meiselman HJ, Weinberg KI, Hiti AL, Malik P (2000) Ineffective erythropoiesis in β-thalassemia major is due to apoptosis at the polychromatophilic normoblast stage. Exp Hematol 28:1343–1353CrossRefPubMed
4.
go back to reference Centis F, Tabellini L, Lucarelli G et al (2000) The importance of erythroid expansion in determining the extent of apoptosis in erythroid precursors in patients with β-thalassemia major. Blood 96:3624–3629PubMed Centis F, Tabellini L, Lucarelli G et al (2000) The importance of erythroid expansion in determining the extent of apoptosis in erythroid precursors in patients with β-thalassemia major. Blood 96:3624–3629PubMed
5.
6.
go back to reference Stefani G, Slack FJ (2008) Small non-coding RNAs in animal development. Nat Rev Mol Cell Biol 9:219–230CrossRefPubMed Stefani G, Slack FJ (2008) Small non-coding RNAs in animal development. Nat Rev Mol Cell Biol 9:219–230CrossRefPubMed
7.
go back to reference Chen CZ, Li L, Lodish HF, Bartel DP (2004) MicroRNAs modulate hematopoietic lineage differentiation. Science 303:83–86CrossRefPubMed Chen CZ, Li L, Lodish HF, Bartel DP (2004) MicroRNAs modulate hematopoietic lineage differentiation. Science 303:83–86CrossRefPubMed
8.
go back to reference Baltimore D, Boldin MP, O'Connell RM, Rao DS, Taganov KD (2008) MicroRNAs: new regulators of immune cell development and function. Nat Immunol 9:839–845CrossRefPubMed Baltimore D, Boldin MP, O'Connell RM, Rao DS, Taganov KD (2008) MicroRNAs: new regulators of immune cell development and function. Nat Immunol 9:839–845CrossRefPubMed
9.
go back to reference Masaki S, Ohtsuka R, Abe Y, Muta K, Umemura T (2007) Expression patterns of microRNAs 155 and 451 during normal human erythropoiesis. Biochem Biophys Res Commun 364:509–514CrossRefPubMed Masaki S, Ohtsuka R, Abe Y, Muta K, Umemura T (2007) Expression patterns of microRNAs 155 and 451 during normal human erythropoiesis. Biochem Biophys Res Commun 364:509–514CrossRefPubMed
10.
go back to reference Zhan M, Miller CP, Papayannopoulou T, Stamatoyannopoulos G, Song CZ (2007) MicroRNA expression dynamics during murine and human erythroid differentiation. Exp Hematol 35:1015–1025CrossRefPubMed Zhan M, Miller CP, Papayannopoulou T, Stamatoyannopoulos G, Song CZ (2007) MicroRNA expression dynamics during murine and human erythroid differentiation. Exp Hematol 35:1015–1025CrossRefPubMed
11.
go back to reference Winichagoon P, Saechan V, Sripanich R, Nopparatana C, Kanokpongsakdi S, Maggio A, Fucharoen S (1999) Prenatal diagnosis of β-thalassaemia by reverse dot-blot hybridization. Prenat Diagn 19:428–435CrossRefPubMed Winichagoon P, Saechan V, Sripanich R, Nopparatana C, Kanokpongsakdi S, Maggio A, Fucharoen S (1999) Prenatal diagnosis of β-thalassaemia by reverse dot-blot hybridization. Prenat Diagn 19:428–435CrossRefPubMed
12.
go back to reference Fucharoen S, Fucharoen G, Fukumaki Y (1990) Simple non-radioactive method for detecting haemoglobin Constant Spring gene. Lancet 335:1527CrossRefPubMed Fucharoen S, Fucharoen G, Fukumaki Y (1990) Simple non-radioactive method for detecting haemoglobin Constant Spring gene. Lancet 335:1527CrossRefPubMed
13.
go back to reference Chong SS, Boehm CD, Cutting GR, Higgs DR (2000) Simplified multiplex-PCR diagnosis of common Southeast Asian deletional determinants of α-thalassemia. Clin Chem 46:1692–1695PubMed Chong SS, Boehm CD, Cutting GR, Higgs DR (2000) Simplified multiplex-PCR diagnosis of common Southeast Asian deletional determinants of α-thalassemia. Clin Chem 46:1692–1695PubMed
14.
go back to reference Dai CH, Krantz SB, Zsebo KM (1991) Human burst-forming units-erythroid need direct interaction with stem cell factor for further development. Blood 78:2493–2497PubMed Dai CH, Krantz SB, Zsebo KM (1991) Human burst-forming units-erythroid need direct interaction with stem cell factor for further development. Blood 78:2493–2497PubMed
15.
go back to reference Bruchova H, Yoon D, Agarwal AM, Mendell J, Prchal JT (2007) Regulated expression of microRNAs in normal and polycythemia vera erythropoiesis. Exp Hematol 35:1657–1667CrossRefPubMed Bruchova H, Yoon D, Agarwal AM, Mendell J, Prchal JT (2007) Regulated expression of microRNAs in normal and polycythemia vera erythropoiesis. Exp Hematol 35:1657–1667CrossRefPubMed
16.
go back to reference Dore LC, Amigo JD, Dos Santos CO et al (2008) A GATA-1-regulated microRNA locus essential for erythropoiesis. Proc Natl Acad Sci USA 105:3333–3338CrossRefPubMed Dore LC, Amigo JD, Dos Santos CO et al (2008) A GATA-1-regulated microRNA locus essential for erythropoiesis. Proc Natl Acad Sci USA 105:3333–3338CrossRefPubMed
17.
go back to reference Pase L, Layton JE, Kloosterman WP, Carradice D, Waterhouse PM, Lieschke GJ (2009) miR-451 regulates zebrafish erythroid maturation in vivo via its target GATA2. Blood 113:1794–1804CrossRefPubMed Pase L, Layton JE, Kloosterman WP, Carradice D, Waterhouse PM, Lieschke GJ (2009) miR-451 regulates zebrafish erythroid maturation in vivo via its target GATA2. Blood 113:1794–1804CrossRefPubMed
18.
go back to reference Chen SY, Wang Y, Telen MJ, Chi JT (2008) The genomic analysis of erythrocyte microRNA expression in sickle cell diseases. PLoS ONE 3:e2360CrossRefPubMed Chen SY, Wang Y, Telen MJ, Chi JT (2008) The genomic analysis of erythrocyte microRNA expression in sickle cell diseases. PLoS ONE 3:e2360CrossRefPubMed
19.
go back to reference Rees DC, Porter JB, Clegg JB, Weatherall DJ (1999) Why are hemoglobin F levels increased in HbE/β-thalassemia. Blood 94:3199–3204PubMed Rees DC, Porter JB, Clegg JB, Weatherall DJ (1999) Why are hemoglobin F levels increased in HbE/β-thalassemia. Blood 94:3199–3204PubMed
20.
go back to reference Bianchi N, Zuccato C, Lampronti I, Borgatti M, Gambari R (2009) Expression of miR-210 during erythroid differentiation and induction of γ-globin gene expression. BMB Rep 42:493–499PubMed Bianchi N, Zuccato C, Lampronti I, Borgatti M, Gambari R (2009) Expression of miR-210 during erythroid differentiation and induction of γ-globin gene expression. BMB Rep 42:493–499PubMed
21.
go back to reference Anguita E, Hughes J, Heyworth C, Blobel GA, Wood WG, Higgs DR (2004) Globin gene activation during haemopoiesis is driven by protein complexes nucleated by GATA-1 and GATA-2. EMBO J 23:2841–2852CrossRefPubMed Anguita E, Hughes J, Heyworth C, Blobel GA, Wood WG, Higgs DR (2004) Globin gene activation during haemopoiesis is driven by protein complexes nucleated by GATA-1 and GATA-2. EMBO J 23:2841–2852CrossRefPubMed
22.
go back to reference Zhu H, Wu H, Liu X, Evans BR, Medina DJ, Liu CG, Yang JM (2008) Role of MicroRNA miR-27a and miR-451 in the regulation of MDR1/P-glycoprotein expression in human cancer cells. Biochem Pharmacol 76:582–588CrossRefPubMed Zhu H, Wu H, Liu X, Evans BR, Medina DJ, Liu CG, Yang JM (2008) Role of MicroRNA miR-27a and miR-451 in the regulation of MDR1/P-glycoprotein expression in human cancer cells. Biochem Pharmacol 76:582–588CrossRefPubMed
23.
go back to reference Bandres E, Bitarte N, Arias F et al (2009) microRNA-451 regulates macrophage migration inhibitory factor production and proliferation of gastrointestinal cancer cells. Clin Cancer Res 15:2281–2290CrossRefPubMed Bandres E, Bitarte N, Arias F et al (2009) microRNA-451 regulates macrophage migration inhibitory factor production and proliferation of gastrointestinal cancer cells. Clin Cancer Res 15:2281–2290CrossRefPubMed
24.
go back to reference Tsuchiya S, Oku M, Imanaka Y et al (2009) MicroRNA-338-3p and microRNA-451 contribute to the formation of basolateral polarity in epithelial cells. Nucleic Acids Res 37:3821–3827CrossRefPubMed Tsuchiya S, Oku M, Imanaka Y et al (2009) MicroRNA-338-3p and microRNA-451 contribute to the formation of basolateral polarity in epithelial cells. Nucleic Acids Res 37:3821–3827CrossRefPubMed
Metadata
Title
Expression of microRNA-451 in normal and thalassemic erythropoiesis
Authors
Saovaros Svasti
Shizuka Masaki
Tipparat Penglong
Yasunobu Abe
Pranee Winichagoon
Suthat Fucharoen
Tsukuru Umemura
Publication date
01-10-2010
Publisher
Springer-Verlag
Published in
Annals of Hematology / Issue 10/2010
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-010-0980-7

Other articles of this Issue 10/2010

Annals of Hematology 10/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.